CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $50,775,837
- in 5 filings, $50.8M under 10b5-1 plans
Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-01 | AFEYAN NOUBAR Director | Sale 10b5-1 | −3,982 | $109.70 | $437K | 2,037,949 |
| 2024-05-01 | AFEYAN NOUBAR Director | Sale 10b5-1 | −4,572 | $110.42 | $505K | 2,033,377 |
| 2024-05-01 | AFEYAN NOUBAR Director | Sale 10b5-1 | −4,246 | $111.55 | $474K | 2,029,131 |
| 2024-05-01 | AFEYAN NOUBAR Director | Sale 10b5-1 | −1,500 | $112.77 | $169K | 2,027,631 |
| 2024-05-01 | AFEYAN NOUBAR Director | Sale 10b5-1 | −700 | $113.40 | $79K | 2,026,931 |
| 2024-04-24 | AFEYAN NOUBAR Director | Sale 10b5-1 | −3,926 | $107.16 | $421K | 2,053,005 |
| 2024-04-24 | AFEYAN NOUBAR Director | Sale 10b5-1 | −5,821 | $108.30 | $630K | 2,047,184 |
| 2024-04-24 | AFEYAN NOUBAR Director | Sale 10b5-1 | −4,153 | $109.04 | $453K | 2,043,031 |
| 2024-04-24 | AFEYAN NOUBAR Director | Sale 10b5-1 | −1,100 | $109.91 | $121K | 2,041,931 |
| 2024-04-17 | AFEYAN NOUBAR Director | Sale 10b5-1 | −8,243 | $103.10 | $850K | 2,063,688 |
| 2024-04-17 | AFEYAN NOUBAR Director | Sale 10b5-1 | −6,475 | $103.69 | $671K | 2,057,213 |
| 2024-04-17 | AFEYAN NOUBAR Director | Sale 10b5-1 | −282 | $104.49 | $29K | 2,056,931 |
| 2024-04-15 | Hoge Stephen President | Sale 10b5-1 | −15,000 | $105.02 | $1.6M | 1,486,241 |
| 2024-04-10 | AFEYAN NOUBAR Director | Sale 10b5-1 | −6,351 | $106.59 | $677K | 2,080,580 |
| 2024-04-10 | AFEYAN NOUBAR Director | Sale 10b5-1 | −7,512 | $107.31 | $806K | 2,073,068 |
| 2024-04-10 | AFEYAN NOUBAR Director | Sale 10b5-1 | −748 | $108.56 | $81K | 2,072,320 |
| 2024-04-10 | AFEYAN NOUBAR Director | Sale 10b5-1 | −389 | $109.36 | $43K | 2,071,931 |
| 2024-04-08 | Mock James M Chief Financial Officer | Sale 10b5-1 | −705 | $101.93 | $72K | 5,048 |
| 2024-04-05 | Mock James M Chief Financial Officer | Exercise or conversion 10b5-1 | +1,453 | 5,753 | ||
| 2024-04-05 | Mock James M Chief Financial Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −1,453 | 14,527 |
Page 32 of 38 · 743 trades